You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 24, 2024

Warner Chilcott Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for WARNER CHILCOTT, and what generic and branded alternatives to WARNER CHILCOTT drugs are available?

WARNER CHILCOTT has eighty-four approved drugs.

Summary for Warner Chilcott

US Patents:	0
Tradenames:	42
Ingredients:	39
NDAs:	84
PTAB Cases with Warner Chilcott as patent owner:	See PTAB cases with Warner Chilcott as patent owner

Drugs and US Patents for Warner Chilcott

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Warner Chilcott	FUROSEMIDE	furosemide	TABLET;ORAL	018419-002	Jan 31, 1983		DISCN	No	No		⤷ Sign Up				⤷ Sign Up
Warner Chilcott	PROCAINAMIDE HYDROCHLORIDE	procainamide hydrochloride	INJECTABLE;INJECTION	089528-001	May 3, 1988		DISCN	No	No		⤷ Sign Up				⤷ Sign Up
Warner Chilcott	CLONIDINE HYDROCHLORIDE	clonidine hydrochloride	TABLET;ORAL	072138-001	Jun 13, 1988		DISCN	No	No		⤷ Sign Up				⤷ Sign Up
Warner Chilcott	DURICEF	cefadroxil/cefadroxil hemihydrate	CAPSULE;ORAL	050512-001	Approved Prior to Jan 1, 1982		DISCN	Yes	No		⤷ Sign Up				⤷ Sign Up
Warner Chilcott	SPIRONOLACTONE	spironolactone	TABLET;ORAL	087952-001	Nov 18, 1982		DISCN	No	No		⤷ Sign Up				⤷ Sign Up
Warner Chilcott	VERAPAMIL HYDROCHLORIDE	verapamil hydrochloride	TABLET;ORAL	070341-001	Sep 24, 1986		DISCN	No	No		⤷ Sign Up				⤷ Sign Up
Warner Chilcott	PROPRANOLOL HYDROCHLORIDE	propranolol hydrochloride	TABLET;ORAL	070438-001	Sep 15, 1986		DISCN	No	No		⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for Warner Chilcott

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Warner Chilcott	ACTONEL WITH CALCIUM (COPACKAGED)	calcium carbonate; risedronate sodium	TABLET;ORAL	021823-001	Aug 12, 2005	5,583,122*PED	⤷ Sign Up
Warner Chilcott	ACTONEL WITH CALCIUM (COPACKAGED)	calcium carbonate; risedronate sodium	TABLET;ORAL	021823-001	Aug 12, 2005	6,096,342*PED	⤷ Sign Up
Warner Chilcott	ACTONEL WITH CALCIUM (COPACKAGED)	calcium carbonate; risedronate sodium	TABLET;ORAL	021823-001	Aug 12, 2005	6,165,513*PED	⤷ Sign Up
Warner Chilcott	ACTONEL WITH CALCIUM (COPACKAGED)	calcium carbonate; risedronate sodium	TABLET;ORAL	021823-001	Aug 12, 2005	6,465,443*PED	⤷ Sign Up
Warner Chilcott	ACTONEL WITH CALCIUM (COPACKAGED)	calcium carbonate; risedronate sodium	TABLET;ORAL	021823-001	Aug 12, 2005	6,432,932*PED	⤷ Sign Up
Warner Chilcott	ACTONEL WITH CALCIUM (COPACKAGED)	calcium carbonate; risedronate sodium	TABLET;ORAL	021823-001	Aug 12, 2005	6,015,801*PED	⤷ Sign Up
Warner Chilcott	ACTONEL WITH CALCIUM (COPACKAGED)	calcium carbonate; risedronate sodium	TABLET;ORAL	021823-001	Aug 12, 2005	5,994,329*PED	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Paragraph IV (Patent) Challenges for WARNER CHILCOTT drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Delayed-release Tablets	200 mg	➤ Subscribe	2013-08-12
➤ Subscribe	Delayed-release Tablets	80 mg	➤ Subscribe	2015-07-01
➤ Subscribe	Delayed-release Tablets	150 mg	➤ Subscribe	2008-12-19
➤ Subscribe	Delayed-release Tablets	200 mg	➤ Subscribe	2014-05-19
➤ Subscribe	Delayed-release Tablets	50 mg	➤ Subscribe	2015-11-05

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.